Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Active as of 2024-11-21 |
Generated Narrative: EvidenceVariable 236965
version: 58; Last updated: 2024-10-03 13:11:20+0000
url: EvidenceVariable OutcomeDefinition: End-stage kidney disease
identifier: FEvIR Object Identifier/236965, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-313960, outcomeId/313960, picoId/85798, sectionId/73215, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.29
version: 2.0.0-ballot
name: End_stage_kidney_disease313960
title: OutcomeDefinition: End-stage kidney disease
shortTitle: End-stage kidney disease
status: Active
date: 2024-11-21 14:09:14+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
End-stage kidney disease
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
author: Computable Publishing®: MAGIC-to-FEvIR Converter:
Type | ResourceReference |
Part Of | MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report) |
handling: dichotomous variable